# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Sensus Healthcare, Inc. (NASDAQ:SRTS), a medical device company specializing in highly effective, non-invasive treatments for b...
Sensus Healthcare (NASDAQ:SRTS) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0....
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...
Physician-run radiation oncology innovator also to research new indications and broaden the market for SRT to include inflammat...